117 related articles for article (PubMed ID: 7660874)
1. The influence of 2-chlorodeoxyadenosine (2-CdA) alone and in combination with cyclophosphamide or methotrexate on normal and leukemic hematopoiesis.
Góra-Tybor J; Robak T
Adv Exp Med Biol; 1994; 370():129-30. PubMed ID: 7660874
[No Abstract] [Full Text] [Related]
2. Synergistic action of 2-chlorodeoxyadenosine and cyclophosphamide on murine leukemias L1210 and P388.
Góra-Tybor J; Robak T
Acta Haematol Pol; 1993; 24(2):177-82. PubMed ID: 8103959
[TBL] [Abstract][Full Text] [Related]
3. Dexamethasone does not enhance antileukemic activity of cladribine in mice with leukemias L1210 and P388.
Robak T; Szmigielska A
Neoplasma; 2000; 47(3):168-71. PubMed ID: 11043840
[TBL] [Abstract][Full Text] [Related]
4. Influence of 2-chloro-2'-deoxyadenosine alone and in combination with cyclophosphamide or methotrexate on murine leukemia L1210.
Góra-Tybor J; Robak T; Warzocha K; Grieb P
Arch Immunol Ther Exp (Warsz); 1994; 42(1):39-42. PubMed ID: 7503633
[TBL] [Abstract][Full Text] [Related]
5. Additive action of gemcitabine (2',2'-difluorodeoxycytidine) and 2-chlorodeoxyadenosine on murine leukemias L1210 and P388.
Marañda E; Szmigielska A; Robak T
Cancer Invest; 1999; 17(2):95-101. PubMed ID: 10071592
[TBL] [Abstract][Full Text] [Related]
6. The influence of 2-chlorodeoxyadenosine alone and in combination with cyclophosphamide or methotrexate on normal hematopoiesis in mice.
Góra-Tybor J; Robak T
Acta Haematol Pol; 1993; 24(3):281-7. PubMed ID: 7902635
[TBL] [Abstract][Full Text] [Related]
7. The effect of cyclosporin A used alone and in combination with either 2-chlorodeoxyadenosine or fludarabine on normal and chronic myelogenous leukemia progenitors in vitro.
Korycka A; Robak T
Arch Immunol Ther Exp (Warsz); 2003; 51(1):61-7. PubMed ID: 12691305
[TBL] [Abstract][Full Text] [Related]
8. Anthracyclines potentiate activity against murine leukemias L1210 and P388 in vivo and in vitro.
Szmigielska-Kaplon A; Ciesielska E; Szmigiero L; Robak T
Eur J Haematol; 2002 Jun; 68(6):370-5. PubMed ID: 12225395
[TBL] [Abstract][Full Text] [Related]
9. The comparison of 2-chlorodeoxyadenosine (2-Cd A) in combination with interferon alpha (IFN alpha) or interferon gamma (IFN gamma) on granulocyte-macrophage progenitor cells (CFU-GM) and clonogenic blasts in (CFU-L) in vitro cultures.
Robak T; Korycka A
Leuk Lymphoma; 1996 Mar; 21(1-2):161-8. PubMed ID: 8907284
[TBL] [Abstract][Full Text] [Related]
10. The influence of recombinant human tumor necrosis factor alpha and its muteins used alone or in combination with 2-chlorodeoxyadenosine on normal and leukemic hematopoiesis in vitro.
Korycka A; Robak T
Leuk Res; 1997 Sep; 21(9):857-65. PubMed ID: 9393601
[TBL] [Abstract][Full Text] [Related]
11. The interaction of 2-chlorodeoxyadenosine (2-CDA) and interferon alpha (IFN-alpha) on normal and myeloid leukemia hematopoiesis in vitro.
Robak T; Korycka A; Góra-Tybor J
Leuk Res; 1994 Apr; 18(4):275-81. PubMed ID: 7909573
[TBL] [Abstract][Full Text] [Related]
12. Complete hematologic remissions in chronic-phase, Philadelphia-chromosome-positive, chronic myelogenous leukemia after 2-chlorodeoxyadenosine.
Saven A; Piro LD; Lemon RH; Figueroa ML; Kosty M; Ellison DJ; Beutler E
Cancer; 1994 Jun; 73(12):2953-63. PubMed ID: 7911068
[TBL] [Abstract][Full Text] [Related]
13. Potentiation of the activity of cisplatin and cyclophosphamide by trimidox, a novel ribonucleotide reductase inhibitor, in leukemia-bearing mice.
Novotny L; Rauko P; Liska J; Elford HL; Szekeres T
Cancer Lett; 2006 Feb; 233(1):178-84. PubMed ID: 15885888
[TBL] [Abstract][Full Text] [Related]
14. The influence of recombinant human tumor necrosis factor-alpha, alone and in combination with cyclophosphamide or methotrexate, on leukemia L1210 and normal hematopoiesis in mice.
Warzocha K; Robak T; Korycka A; Graczyk J; Pakulska W; Gałazka G; Kłysik J
Arch Immunol Ther Exp (Warsz); 1991; 39(5-6):587-95. PubMed ID: 1841555
[TBL] [Abstract][Full Text] [Related]
15. Interrupting the inhibiton of normal hematopoiesis in myelogenous leukemia: a hypothetical approach to therapy.
Lichtman MA
Stem Cells; 2000; 18(5):304-6. PubMed ID: 11007914
[No Abstract] [Full Text] [Related]
16. Interaction of 2-chlorodeoxyadenosine in combination either with interferons or recombinant human tumor necrosis factor alpha on myeloid progenitor cells in vitro.
Korycka A; Robak T
Arch Immunol Ther Exp (Warsz); 1996; 44(4):259-64. PubMed ID: 9017167
[TBL] [Abstract][Full Text] [Related]
17. [Clinical pharmacology of 2-chlorodeoxyadenosine (Cladribine)].
Góra-Tybor J; Robak T
Przegl Lek; 1996; 53(8):614-8. PubMed ID: 8999463
[TBL] [Abstract][Full Text] [Related]
18. Influence of gemcitabine (2',2'-difluoro-deoxycytidine) and 2-chlorodeoxyadenosine on growth of normal and leukemic cells in vitro.
Lech-Marańda E; Korycka A; Robak T
Eur J Haematol; 2000 Nov; 65(5):317-21. PubMed ID: 11092462
[TBL] [Abstract][Full Text] [Related]
19. 2-chlorodeoxyadenosine administration to patients with the myeloid blast phase of chronic myelogenous leukemia.
Gollard R; Miller WE; Piro LD; Saven A
Leuk Lymphoma; 1997 Dec; 28(1-2):183-5. PubMed ID: 9498718
[TBL] [Abstract][Full Text] [Related]
20. Purine analogs (fludarabine and 2-chlorodeoxyadenosine) as apoptosis-inducing drugs in CML therapy.
Martinelli G; Zinzani PL; Farabegoli P
Haematologica; 1996; 81(3):286-7. PubMed ID: 8767537
[No Abstract] [Full Text] [Related]
[Next] [New Search]